MedTrace Logo

MIFI Flutter Registry - Ablation of Atrial Flutter With IntellaTip Sensor Technology

NCT02810938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2019-10-01

No results posted yet for this study

Summary

* Prospective Atrial Flutter Ablation Registry investigating IntellaTip Mifi XP 8 mm technology and MVG isthmus ablation approach
* Design: National, multi-centre, prospective observational registry documenting right atrial isthmus ablation
* Observational treatment: Combination of MVG ablation strategy and the IntellaTip Mifi XP 8 mm sensor technology
* Duration: Patients will be followed for 6 months post-ablation

Conditions

  • Atrial Flutter

Interventions

DEVICE

Ablation of atrial flutter

Ablation of atrial flutter using IntellaTip Mifi 8 mm technology in combination with Maximum voltage-guided ablation approach

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Thorsten Lewalter, MD, PhD · Head, Dept. of Medicine-Cardiology and Intensive Care

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-02-16
Completion
2018-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02810938 on ClinicalTrials.gov